CYBERARK SOFTWARE LTD/ISRAEL (CYBR) Stock Fundamental Analysis
NASDAQ:CYBR - Nasdaq - IL0011334468 - Common Stock - Currency: USD
We assign a fundamental rating of 5 out of 10 to CYBR. CYBR was compared to 282 industry peers in the Software industry. No worries on liquidiy or solvency for CYBR as it has an excellent financial health rating, but there are worries on the profitability. CYBR is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
CYBR had positive earnings in the past year.
In the past year CYBR had a positive cash flow from operations.
CYBR had negative earnings in each of the past 5 years.
CYBR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CYBR has a Return On Assets (-2.62%) which is in line with its industry peers.
CYBR has a Return On Equity of -3.60%. This is in the better half of the industry: CYBR outperforms 61.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.62% | ||
| ROE | -3.6% | ||
| ROIC | N/A |
ROA(3y)-4.42%
ROA(5y)-3.71%
ROE(3y)-10.52%
ROE(5y)-8.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CYBR has a better Gross Margin (77.91%) than 75.89% of its industry peers.
CYBR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CYBR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 77.91% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-1.54%
2. Health
2.1 Basic Checks
CYBR does not have a ROIC to compare to the WACC, probably because it is not profitable.
CYBR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CYBR has been increased compared to 5 years ago.
There is no outstanding debt for CYBR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
CYBR has an Altman-Z score of 12.70. This indicates that CYBR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CYBR (12.70) is better than 88.30% of its industry peers.
There is no outstanding debt for CYBR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 12.7 |
ROIC/WACCN/A
WACC9.91%
2.3 Liquidity
CYBR has a Current Ratio of 1.29. This is a normal value and indicates that CYBR is financially healthy and should not expect problems in meeting its short term obligations.
CYBR has a Current ratio (1.29) which is in line with its industry peers.
CYBR has a Quick Ratio of 1.29. This is a normal value and indicates that CYBR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CYBR (1.29) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
CYBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.19%, which is quite impressive.
Measured over the past 5 years, CYBR shows a small growth in Earnings Per Share. The EPS has been growing by 1.81% on average per year.
CYBR shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.13%.
The Revenue has been growing by 18.19% on average over the past years. This is quite good.
EPS 1Y (TTM)62.19%
EPS 3Y111.56%
EPS 5Y1.81%
EPS Q2Q%30.67%
Revenue 1Y (TTM)35.13%
Revenue growth 3Y25.78%
Revenue growth 5Y18.19%
Sales Q2Q%43.35%
3.2 Future
The Earnings Per Share is expected to grow by 27.96% on average over the next years. This is a very strong growth
CYBR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.17% yearly.
EPS Next Y28.5%
EPS Next 2Y27.96%
EPS Next 3Y29.78%
EPS Next 5Y27.96%
Revenue Next Year33.63%
Revenue Next 2Y26.38%
Revenue Next 3Y24.47%
Revenue Next 5Y24.17%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 115.51, CYBR can be considered very expensive at the moment.
CYBR's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.17. CYBR is valued rather expensively when compared to this.
CYBR is valuated quite expensively with a Price/Forward Earnings ratio of 75.90.
The rest of the industry has a similar Price/Forward Earnings ratio as CYBR.
When comparing the Price/Forward Earnings ratio of CYBR to the average of the S&P500 Index (22.10), we can say CYBR is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 115.51 | ||
| Fwd PE | 75.9 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CYBR is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 74.62 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CYBR does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CYBR's earnings are expected to grow with 29.78% in the coming years.
PEG (NY)4.05
PEG (5Y)63.8
EPS Next 2Y27.96%
EPS Next 3Y29.78%
5. Dividend
5.1 Amount
No dividends for CYBR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:CYBR (5/29/2025, 9:51:00 AM)
376.56
-4.64 (-1.22%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners91.4%
Inst Owner Change0.45%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap18.62B
Analysts85.91
Price Target448.34 (19.06%)
Short Float %2.23%
Short Ratio1.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.67%
Min EPS beat(2)9.13%
Max EPS beat(2)22.2%
EPS beat(4)4
Avg EPS beat(4)41.57%
Min EPS beat(4)9.13%
Max EPS beat(4)101.67%
EPS beat(8)8
Avg EPS beat(8)75.35%
EPS beat(12)12
Avg EPS beat(12)62.19%
EPS beat(16)15
Avg EPS beat(16)50.27%
Revenue beat(2)2
Avg Revenue beat(2)2.15%
Min Revenue beat(2)2.01%
Max Revenue beat(2)2.3%
Revenue beat(4)4
Avg Revenue beat(4)1.36%
Min Revenue beat(4)0.54%
Max Revenue beat(4)2.3%
Revenue beat(8)7
Avg Revenue beat(8)1.56%
Revenue beat(12)8
Avg Revenue beat(12)0.45%
Revenue beat(16)9
Avg Revenue beat(16)0.16%
PT rev (1m)-2.3%
PT rev (3m)-1.51%
EPS NQ rev (1m)3.57%
EPS NQ rev (3m)2.34%
EPS NY rev (1m)4.51%
EPS NY rev (3m)4.22%
Revenue NQ rev (1m)1.58%
Revenue NQ rev (3m)2.14%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 115.51 | ||
| Fwd PE | 75.9 | ||
| P/S | 16.98 | ||
| P/FCF | 74.62 | ||
| P/OCF | 71.15 | ||
| P/B | 7.67 | ||
| P/tB | 43.61 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.26
EY0.87%
EPS(NY)4.96
Fwd EY1.32%
FCF(TTM)5.05
FCFY1.34%
OCF(TTM)5.29
OCFY1.41%
SpS22.18
BVpS49.08
TBVpS8.64
PEG (NY)4.05
PEG (5Y)63.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.62% | ||
| ROE | -3.6% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 77.91% | ||
| FCFM | 22.76% |
ROA(3y)-4.42%
ROA(5y)-3.71%
ROE(3y)-10.52%
ROE(5y)-8.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-1.54%
F-Score4
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 17.53% | ||
| Cap/Sales | 1.11% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 12.7 |
F-Score4
WACC9.91%
ROIC/WACCN/A
Cap/Depr(3y)43.07%
Cap/Depr(5y)47.67%
Cap/Sales(3y)1.29%
Cap/Sales(5y)1.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.19%
EPS 3Y111.56%
EPS 5Y1.81%
EPS Q2Q%30.67%
EPS Next Y28.5%
EPS Next 2Y27.96%
EPS Next 3Y29.78%
EPS Next 5Y27.96%
Revenue 1Y (TTM)35.13%
Revenue growth 3Y25.78%
Revenue growth 5Y18.19%
Sales Q2Q%43.35%
Revenue Next Year33.63%
Revenue Next 2Y26.38%
Revenue Next 3Y24.47%
Revenue Next 5Y24.17%
EBIT growth 1Y-13.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.82%
EBIT Next 3Y45.05%
EBIT Next 5YN/A
FCF growth 1Y1271.32%
FCF growth 3Y49.72%
FCF growth 5Y10.39%
OCF growth 1Y758.3%
OCF growth 3Y45.88%
OCF growth 5Y10.35%